Antifungal Topical Therapy in Oral Candidosis. A Comparative Study.

LOPEZ S, SOLATI-MUGNOLO N, FEMOPASE F, BENITEZ M, MORELATTO R, ASTRADA-VERDE L AND MASIH DT

Medina Oral

Año: 2002 vol. 7 p. 265 - 265

i> The aim of the present paper was to evaluate the effect of fenticonazole and to compare it with that of ketoconazole and nystatin in the topical treatment of oral chronic candidosis. Eighty patients diagnosed with erythematous chronic candidosis were divided into four groups, according to the cream they were provided with 3% fenticonazole, 2% fenticonazole, 100000UI nystatin, and 2% ketoconazole in orabase respectively. A clinical assessment was made at 7, 15, 30 and 45 days. Fifty-one of them finished the trial. ANOVA, Kruskall Wallis and Wilcoxon tests were applied for statistical analysis. There was a significative decrease of the oral lesions in all groups (p